التقنية والذكاء الاصطناعي
Amazon Prime Day Deals Under $50 in October 2026
Everything is expensive. Treat yourself to one of these WIRED-approved Prime Day picks under $50.
WIRED ·
ابحث في العناوين
“Treat”
7
العلوم والبيئة
Exploring systemic racism as the default explanation for disparities
Much of the field of sociology treats systemic racism as its default explanation for racial disparities rather than as an open question that requires further investigation and evidence, according to a recent position paper. The assumptions and moralization surrounding the origins
Phys.org - latest science and technology news stories ·
التقنية والذكاء الاصطناعي
This startup is issuing AI-generated acne prescriptions
People in Utah can now use AI to get a prescription for acne treatment. On Monday, healthcare startup Nolla Health announced that users in the state can scan their faces using its app, allowing its AI system to analyze acne severity and autonomously write a prescription, as repor
The Verge ·
الرياضة والنتائج المباشرة
Bournemouth unhappy over Scott injury but Tuchel says England took ‘zero risk’
Midfielder may be out for two months with thigh injury Scott played in pain but Tuchel says he got ‘green light’ Thomas Tuchel has insisted England took zero risk with Alex Scott after the midfielder’s withdrawal with a thigh injury left Bournemouth unhappy over his treatment. Sc
Sport | The Guardian ·
أخبار العالم
Who Owns the Moon?
A treaty from the 1960s declared that nobody can own outer space. Half a century later, billionaires and superpowers see fortunes to be made nonetheless.
NYT > World News ·
BU
الأعمال والاقتصاد
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
Business News ·
AL
العلوم والبيئة
Cancer stem cells have an “energy addiction” scientists may be able to exploit
High-risk MDS stem cells appear to have an unexpected “energy addiction,” relying far more heavily than healthy blood-forming cells on a molecule called NAD. Disrupting this energy pathway selectively weakened the cancer-driving cells, revealing a potential new target for treatme
All Top News -- ScienceDaily ·